USANA's 2026 Strategy Balances Growth, Efficiency and $1M Workforce Cuts

USANA Health Sciences has outlined its strategic priorities for fiscal 2026, focusing on growth and efficiency. The company expects a 4% increase in consolidated net sales, with key contributions from Rise Wellness and HYA. Cost-cutting measures and technology upgrades are also part of the plan to strengthen competitiveness.

The company recently reduced its workforce by around 10% in the fourth quarter, saving roughly $1 million annually. This move aligns with efforts to streamline operations while investing in future growth. Inventory levels climbed by $35 million, or 48%, reaching $107 million by the end of 2025—80% of which came from Rise Wellness and HYA stock.

New product launches in major retailers will rely on these inventory investments. Rise Wellness, however, is projected to break even in 2026, with a lower gross margin than expected. Meanwhile, the company anticipates a high effective tax rate of 55% to 60% for the year.

Expansion plans include broadening retail partnerships and diversifying revenue beyond China. Technology modernisation and greater AI adoption will play a central role in maintaining an edge. The shift toward a science-driven, omnichannel wellness model remains a core objective for 2026.

USANA's strategy centres on balancing growth with cost efficiency. The focus on Rise Wellness and HYA, alongside retail expansion, aims to drive sales. With inventory investments supporting new launches, the company looks to solidify its market position in the coming year.